DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trileptal (Oxcarbazepine) - Dysphagia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dysphagia ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Trileptal (Oxcarbazepine) where reactions include dysphagia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Trileptal side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient: female

Reactions: Eye Discharge, Mouth Ulceration, Petechiae, Pyrexia, Oropharyngeal Pain, Transaminases Increased, Erythema, LIP Erosion, Dermatitis, Liver Function Test Abnormal, Skin Lesion, Oral Mucosa Erosion, Stevens-Johnson Syndrome, Cough, Blister, Swelling Face, Dysphagia, Rhinitis, Vaginal Discharge, Rash, Respiratory Distress, Eye Pain, Alopecia, Dysuria, Eye Swelling, Rash Maculo-Papular, Vaginal Lesion

Drug(s) suspected as cause:
Trileptal

Other drugs received by patient: Nafcillin; Prednisolone; Propofol; Precedex; Benadryl



Possible Trileptal side effects in female

Reported by a lawyer from United States on 2012-08-14

Patient: female, weighing 56.2 kg (123.7 pounds)

Reactions: Abdominal Pain, Pruritus, Vulval Ulceration, Urticaria, Pyrexia, Headache, Oral Candidiasis, Lymph Node Palpable, Hypoxia, Sputum Purulent, Proctalgia, Blister, Blood Gases Abnormal, Dysphagia, Stomatitis, Encephalomalacia, Coronary Artery Disease, Toxic Epidermal Necrolysis, Vaginal Discharge, Periorbital Oedema, Cachexia, Colonoscopy Abnormal, Acute Sinusitis, Rash Erythematous, Insomnia, Aspartate Aminotransferase Increased, Dehydration, Confusional State, Skin Exfoliation, Mouth Ulceration, Nuclear Magnetic Resonance Imaging Brain Abnormal, Hepatitis, Constipation, Death, Blood Calcium Decreased, Haematocrit Decreased, Chest Pain, Blood Sodium Decreased, Blood Glucose Increased, Vomiting, Blood Alkaline Phosphatase, Nausea, Alanine Aminotransferase Increased, Blood Potassium Increased, Facial Pain, Mucosal Inflammation, Haemoglobin Decreased, Oral Pain, Neoplasm Malignant, Respiratory Failure, Asthenia, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Trileptal
    Indication: Convulsion
    Start date: 2003-01-29
    End date: 2003-01-31

Dilantin
    Indication: Convulsion
    Start date: 2002-12-01

Other drugs received by patient: Ceftriaxone; Acyclovir; Triamcinolone; Nystatin; Gyne-Lotrimin; Pepcid; Fluconazole; Docusate; Neurontin



Possible Trileptal side effects in male

Reported by a consumer/non-health professional from Mexico on 2012-08-10

Patient: male

Reactions: Speech Disorder, Dysphagia, Brain Oedema, Paralysis

Drug(s) suspected as cause:
Trileptal



Possible Trileptal side effects in female

Reported by a consumer/non-health professional from Brazil on 2012-06-25

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Speech Disorder, Dysphagia, Hepatic Calcification, Hypothyroidism, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Trileptal

Other drugs received by patient: Ursacol; Levoid; Lamotrigine; Valproate Sodium



Possible Trileptal side effects in female

Reported by a consumer/non-health professional from Brazil on 2012-05-23

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Speech Disorder, Dysphagia, Hepatic Calcification, Hypothyroidism, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Trileptal

Other drugs received by patient: Lamotrigine; Levoid; Valproate Sodium; Ursacol



Possible Trileptal side effects in 76 year old male

Reported by a physician from Spain on 2012-05-14

Patient: 76 year old male

Reactions: Dysphagia, Aspiration Bronchial, General Physical Health Deterioration, Gait Disturbance, Somnolence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-07-01
    End date: 2010-09-24

Trileptal
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-07-01
    End date: 2010-09-24

Other drugs received by patient: Fluoxetine HCL; Risperdal



Possible Trileptal side effects in 76 year old male

Reported by a physician from Spain on 2012-05-09

Patient: 76 year old male

Reactions: General Physical Condition Abnormal, Dysphagia, Aspiration Bronchial, Drug Interaction, Gait Disturbance, Somnolence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Trileptal

Other drugs received by patient possibly interacting with the suspect drug:
Keppra
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-07-01
    End date: 2010-09-24

Other drugs received by patient: Fluoxetine; Risperdal



Possible Trileptal side effects in male

Reported by a physician from France on 2011-11-15

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Lymphadenopathy, Blood Creatine Phosphokinase Increased, Respiratory Disorder, High Density Lipoprotein Increased, Urinary Incontinence, Visual Acuity Reduced, Ulcerative Keratitis, Pyrexia, Transaminases Increased, Obstructive Uropathy, C-Reactive Protein Increased, Dermatitis Bullous, Acute Respiratory Distress Syndrome, Mucous Membrane Disorder, Cough, Back Pain, Medical Device Complication, Dysphagia, Toxic Epidermal Necrolysis, Corneal Opacity, Prothrombin Time Ratio Decreased, Blood Creatine Phosphokinase MB Increased, Heart Rate Decreased, Rash Erythematous, Renal Colic, Corneal Neovascularisation, Skin Exfoliation, Eye Discharge, Scab, Symblepharon, Nephrolithiasis, Photophobia, Microlithiasis, Bone Marrow Failure, Thrombocytopenia, Renal Failure Acute, Cataract, Epilepsy, Iris Adhesions, Alopecia, Lacrimation Decreased, Gait Disturbance, Asthenia, Leukopenia

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Depakene
    Dosage: 1 g daily
    Administration route: Oral
    Indication: Partial Seizures
    Start date: 2004-11-23
    End date: 2004-11-23

Trileptal
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Partial Seizures
    Start date: 2005-02-14
    End date: 2005-02-21

Depakene
    Dosage: 1.5 g daily
    Start date: 2004-11-24
    End date: 2005-02-21

Depakene
    Dosage: 1.6 g daily
    Indication: Partial Seizures
    End date: 2004-11-22

Aspegic 325
    Indication: Influenza Like Illness
    Start date: 2005-02-01

Other drugs received by patient: Levetiracetam; Clobazam; Topiramate; Clonazepam

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012